Rickettsiosis Treatment Guidelines

Introduction to Treatment

• The Centers for Disease Control and Prevention (CDC) recommends doxycycline as the treatment of choice for all tick-borne rickettsioses in patients of all ages, including children under 8 years, and it should be started empirically upon clinical suspicion without waiting for laboratory confirmation 1

Dosage and Administration

• The recommended dosage for doxycycline is 100 mg twice a day (oral or intravenous) for adults, and 2.2 mg/kg twice a day (oral or intravenous) for children under 45 kg, with a duration of 5-7 days and at least 3 days after fever subsides, as recommended by the CDC and the American Academy of Pediatrics 1
• Oral administration is suggested for early/mild disease in outpatient patients, and intravenous administration is recommended for hospitalized patients, especially those who are severely ill, vomiting, or have altered mental status, with a strength of evidence indicating that the benefits outweigh the risks 1

Treatment Outcomes

• Delaying treatment is directly related to worse clinical outcomes, with hospitalization rates, ICU admission rates, and mortality rates increasing with each day of delayed treatment, as demonstrated in the following table:

1

• Fever typically subsides within 24-48 hours after treatment initiation when doxycycline is started within the first 4-5 days of illness, and lack of improvement within 48 hours of treatment initiation suggests alternative diagnosis or coinfection 1

Alternative Treatments

• Chloramphenicol is an inferior alternative to doxycycline for Rocky Mountain Spotted Fever (RMSF) and is not effective for ehrlichiosis or anaplasmosis, with caution advised in third-trimester use due to risk of gray baby syndrome, and requires monitoring of blood indices due to potential hematologic effects 1
• Rifampin may be considered as an alternative only for mild cases of anaplasmosis in pregnancy or documented allergy to tetracyclines, with a dosage of 300 mg orally twice a day for adults or 10 mg/kg (maximum 300 mg/dose) for children, as recommended by the CDC guidelines 1

Safety and Efficacy

• Recent studies demonstrate that short courses of doxycycline do not cause tooth staining or enamel hypoplasia, with a prevalence rate of 0% (95% CI: 0%-3%) among children treated with short courses of doxycycline, and the benefits of doxycycline treatment outweigh the risks in pregnant women with rickettsiosis, according to the CDC guidelines and other authorities 1, 2
• Patient counseling should include discussion of risks versus benefits with the pregnant woman, and severe doxycycline allergy may require consultation with an allergy specialist for possible desensitization in an inpatient setting 1

Prevention and Prophylaxis

• Prophylactic use of antibiotics after tick bites in asymptomatic individuals is not recommended by the CDC or the American Academy of Pediatrics, and the most effective preventive measures include limiting exposure to ticks, thorough body inspection after outdoor activities, prompt removal of attached ticks, and use of insect repellents, as recommended by 2 and 1]
• Common mistakes to avoid include delaying treatment while awaiting laboratory confirmation, assuming a rash must be present, using ineffective antibiotics, withholding doxycycline from children under 8 years due to outdated concerns about tooth staining, and failing to consider coinfection when response to treatment is inadequate, with discharging patients without proper evaluation potentially leading to fatal outcomes, according to 1 and 2]

Laboratory Diagnosis

• A complete blood count, comprehensive metabolic panel, peripheral blood smear, blood cultures, and serologic testing for common TBRDs should be performed as part of the essential laboratory workup, with antibody tests typically negative in the first week of illness, according to the CDC guidelines 1
• The CDC guidelines suggest the following laboratory findings are common in TBRDs:

Hospitalization and Follow-up

• Hospitalization should be considered for patients with evidence of organ dysfunction, severe thrombocytopenia, mental status changes, or need for supportive therapy, with close follow-up essential for patients treated as outpatients, according to the CDC guidelines 1
• Rickettsial diseases may present with thrombocytopenia, slight elevations in hepatic transaminases, and hyponatremia, particularly as the disease advances, in patients with rickettsial diseases 1